Actively Recruiting
Study to ONO-4538 in Patients With Rhabdoid Tumor
Led by Ono Pharmaceutical Co., Ltd. · Updated on 2026-03-12
23
Participants Needed
5
Research Sites
278 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Investigate the efficacy and safety of ONO-4538 for the treatment of rhabdoid Tumors
CONDITIONS
Official Title
Study to ONO-4538 in Patients With Rhabdoid Tumor
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 1 year or older at the time of consent
- Patients who are refractory or intolerant to one or more chemotherapy treatments for rhabdoid tumors
- Patients with advanced or recurrent rhabdoid tumors not eligible for curative surgery
You will not qualify if you...
- Patients with a history of active concurrent malignancy or serious complications
- Patients with spinal lesions expected to require radiation therapy or surgery during the study
- Patients with uncontrolled central nervous system disorders other than AT/RT that could cause stopping the study drug
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Nagoya University Hospital
Nagoya, Aichi-ken, Japan
Actively Recruiting
2
Hokkaido University Hospital
Sapporo, Hokkaido, Japan, 060-8648
Actively Recruiting
3
Hyogo Prefectural Kobe Children's Hospital
Kobe, Hyōgo, Japan
Actively Recruiting
4
Osaka City General Hospital
Osaka, Osaka, Japan
Actively Recruiting
5
National Cancer Center Hospital
Chuo-ku, Tokyo, Japan
Actively Recruiting
Research Team
N
North America Clinical Trial Support Desk
CONTACT
I
International Clinical Trial Support Desk
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here